These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Downregulation of Nogo-B ameliorates cerebral ischemia/reperfusion injury in mice through regulating microglia polarization via TLR4/NF-kappaB pathway. Gong P, Jia HY, Li R, Ma Z, Si M, Qian C, Zhu FQ, Sheng-Yong L. Neurochem Int; 2023 Jul; 167():105553. PubMed ID: 37230196 [Abstract] [Full Text] [Related]
7. Shikonin attenuates cerebral ischemia/reperfusion injury via inhibiting NOD2/RIP2/NF-κB-mediated microglia polarization and neuroinflammation. Yang Y, Fei Y, Xu X, Yao J, Wang J, Liu C, Ding H. J Stroke Cerebrovasc Dis; 2024 Jun; 33(6):107689. PubMed ID: 38527567 [Abstract] [Full Text] [Related]
13. Inflammatory mechanism of cerebral ischemia-reperfusion injury with treatment of stepharine in rats. Hao T, Yang Y, Li N, Mi Y, Zhang G, Song J, Liang Y, Xiao J, Zhou D, He D, Hou Y. Phytomedicine; 2020 Dec; 79():153353. PubMed ID: 33007731 [Abstract] [Full Text] [Related]
14. NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia-reperfusion damage. Tang X, Zhong W, Tu Q, Ding B. Neurol Res; 2014 Feb; 36(2):118-25. PubMed ID: 24131725 [Abstract] [Full Text] [Related]
16. Ginkgolide C attenuates cerebral ischemia/reperfusion-induced inflammatory impairments by suppressing CD40/NF-κB pathway. Li B, Zhang B, Li Z, Li S, Li J, Wang A, Hou J, Xu J, Zhang R. J Ethnopharmacol; 2023 Aug 10; 312():116537. PubMed ID: 37094696 [Abstract] [Full Text] [Related]
17. Equol is neuroprotective during focal cerebral ischemia and reperfusion that involves p-Src and gp91(phox). Yu W, Wang Y, Zhou DX, Zhao LM, Li GR, Deng XL. Curr Neurovasc Res; 2014 Aug 10; 11(4):367-77. PubMed ID: 25198009 [Abstract] [Full Text] [Related]
18. Maraviroc, an inhibitor of chemokine receptor type 5, alleviates neuroinflammatory response after cerebral Ischemia/reperfusion injury via regulating MAPK/NF-κB signaling. Chen B, Cao P, Guo X, Yin M, Li X, Jiang L, Shao J, Chen X, Jiang C, Tao L, Zhou L, Yu H. Int Immunopharmacol; 2022 Jul 10; 108():108755. PubMed ID: 35395466 [Abstract] [Full Text] [Related]